Tamoxifen citrate and Laryngitis - a phase IV clinical study of FDA data
Laryngitis is found among people who take Tamoxifen citrate, especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years.
The phase IV clinical study analyzes which people take Tamoxifen citrate and have Laryngitis. It is created by eHealthMe based on reports of 9,878 people who have side effects when taking Tamoxifen citrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
9,878 people reported to have side effects when taking Tamoxifen citrate.
Among them, 34 people (0.34%) have Laryngitis.
What is Tamoxifen citrate?
Tamoxifen citrate has active ingredients of tamoxifen citrate. It is often used in breast cancer. eHealthMe is studying from 10,995 Tamoxifen citrate users for its effectiveness, alternative drugs and more.
What is Laryngitis?
Laryngitis (inflammation of the larynx) is found to be associated with 1,292 drugs and 756 conditions by eHealthMe.
Number of Tamoxifen citrate and Laryngitis reports submitted per year:
Time on Tamoxifen citrate when people have Laryngitis *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 100 %
- 10+ years: 0.0 %
Gender of people who have Laryngitis when taking Tamoxifen citrate *:
- female: 100 %
- male: 0.0 %
Age of people who have Laryngitis when taking Tamoxifen citrate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 5.88 %
- 40-49: 0.0 %
- 50-59: 94.12 %
- 60+: 0.0 %
Common drugs people take besides Tamoxifen citrate *:
- Ambien: 29 people, 85.29%
- Zometa: 26 people, 76.47%
- Carboplatin: 20 people, 58.82%
- Taxol: 20 people, 58.82%
- Wellbutrin: 19 people, 55.88%
- Arimidex: 19 people, 55.88%
- Effexor: 19 people, 55.88%
- Aredia: 18 people, 52.94%
- Vicodin: 16 people, 47.06%
- Femara: 16 people, 47.06%
Common side effects people have besides Laryngitis *:
- Osteonecrosis Of Jaw (death of bone of jaw): 22 people, 64.71%
- Dizziness: 22 people, 64.71%
- Osteomyelitis (infection of bone): 21 people, 61.76%
- Spinal Osteoarthritis (joint cartilage loss in spine): 21 people, 61.76%
- Chest Pain: 21 people, 61.76%
- Pain: 19 people, 55.88%
- Jaw Fracture: 19 people, 55.88%
- Injury: 19 people, 55.88%
- Insomnia (sleeplessness): 19 people, 55.88%
- Neuropathy Peripheral (surface nerve damage): 18 people, 52.94%
Common conditions people have *:
- Sleep Disorder: 12 people, 35.29%
- Joint Pain: 10 people, 29.41%
- Depression: 10 people, 29.41%
- Breast Cancer Recurrent: 10 people, 29.41%
- Anaemia (lack of blood): 10 people, 29.41%
- Breast Cancer Metastatic: 5 people, 14.71%
- Osteoporosis (bones weak and more likely to break): 2 people, 5.88%
- Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 5.88%
- Breast Cancer In Situ: 1 person, 2.94%
* Approximation only. Some reports may have incomplete information.
Do you take Tamoxifen citrate and have Laryngitis?Check whether Laryngitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- K?rm?z?bekmez H, Yesiltepe Mutlu RG, Dursun F, ??güven ?P, "Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome", Journal of Pediatric Endocrinology and Metabolism, 2015 Sep .
Alternative drugs to, pros and cons of Tamoxifen citrate:
- Tamoxifen citrate (10,995 reports)
Laryngitis treatments and more:
- Laryngitis (10,047 reports)
COVID vaccines that are related to Laryngitis:
- Laryngitis in Moderna COVID Vaccine
- Laryngitis in Pfizer BioNTech Covid Vaccine
- Laryngitis in Johnson and Johnson Covid Vaccine
How severe was Laryngitis and when was it recovered:
Expand to all the drugs that have ingredients of tamoxifen citrate:
Common drugs associated with Laryngitis:
All the drugs that are associated with Laryngitis:
- Laryngitis (1,292 drugs)
Common conditions associated with Laryngitis:
All the conditions that are associated with Laryngitis:
- Laryngitis (756 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tamoxifen citrate (the active ingredients of Tamoxifen citrate) and Tamoxifen citrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.